
    
      Objective of this pivotal study was to assess the bioequivalence between Test Product:
      Risperidone Tablet 1 mg of Ipca Laboratories Limited, India and the corresponding Reference
      Product: RisperdalÂ® (Risperidone) Tablets 25 mg of Janssen Pharmaceutica Products, USA, under
      fed condition in normal, healthy, adult, human subjects in a randomized crossover study.

      The study was conducted with 48 healthy adult subjects. In each study period, a single 1 mg
      dose of either test or reference was administered to the subjects as per the randomization
      schedule in each study period with about 240 mL of water at ambient temperature in sitting
      position.

      The duration of the clinical phase was approximately 16 days including washout period of at
      least 10 days between administrations of study drug in each study period.
    
  